Management Challenges of Severe, Complex Dyskinesia. Data from a Large Cohort of Patients Treated with Levodopa-Carbidopa Intestinal Gel for Advanced Parkinson's Disease.
József Attila SzászViorelia Adelina ConstantinKároly Orbán-KisLigia Ariana BancuMarius CiorbaIstván MihályElőd Ernő NagyRóbert Máté SzászKrisztina KelemenMihaela Adriana SimuSzabolcs SzatmáriPublished in: Brain sciences (2021)
Patients with APD with complex dyskinesias must be tested in dedicated hospitals, and they need a special therapeutic approach. The properly adapted LCIG treatment regarding the dose and time of administration completed with well-selected add-on medication should offer improvement for patients who want to or can only choose this DAT vs. others.